NAS
WST icon

Nykredit A/S’s West Pharmaceutical WST Stock Holding History

Nykredit A/S’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.48M Buy
+26,405
New +$8.07M 0.03% 397

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nykredit A/S's WST Position: Q2 2026 in Review

Nykredit A/S opened a new position in West Pharmaceutical (WST) in Q2 2026: 26,405 shares worth $9.48M. The stake represents 0.03% of the portfolio and ranks #397 among its holdings.

654 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Nykredit A/S held 26,405 shares of West Pharmaceutical worth $9.48M as of Q2 2026.
  • West Pharmaceutical was a new Nykredit A/S position in Q2 2026.
  • West Pharmaceutical made up 0.03% of Nykredit A/S's portfolio in Q2 2026, its #397 holding.
  • 654 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.